Skip to main content

Biora Therapeutics, Inc.

BIORDelisted Jun 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001580063

Biora Therapeutics, Inc. was delisted on Jun 4, 2025; its insiders filed their last Form 4 on Dec 16, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $6.13M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Biora Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of BIOR: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders49147−1
Shares49.3M89049.7M+400.7K (+0.8%)
Value$34.5M$1.00K$24.1M−$10.4M (−30.2%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held Biora Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to BIOR in Q3 2022
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP812,337$394.0K0.05%
XR Securities LLC10,872$5.00K0.00%
Virtu Financial LLC10,312$5.00K0.00%
Bank of America Corp390$00.00%
Riggs Asset Managment Co. Inc.550$00.00%
Steward Partners Investment Advisory, LLC800$00.00%

Sold out (7)

Institutions that held Biora Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of BIOR in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Engineers Gate Manager LP11,420$8.00K
Group One Trading, L.P.9,192$6.00K
Captrust Financial Advisors2,280$2.00K
Citigroup Inc1,027$1.00K
Tucker Asset Management LLC500$350
Simplex Trading, LLC501$0
Surevest, LLC200$0

Not filed for Q3 2022 yet (1)

Institutions that held Biora Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BIOR in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Urban Wealth Management, LLC890$1.00K